Solomon D H, Chopra I J, Chopra U, Smith F J
N Engl J Med. 1977 Jan 27;296(4):181-6. doi: 10.1056/NEJM197701272960401.
We attempted to determine if euthyroid Graves's ophthalmopathy is a single entity or a heterogeneous group of disorders. Activity of long acting thyroid stimulator protector occurred in 31 of 33 patients with Graves's hyperthyroidism but in only nine of 17 with euthyroid Graves's ophthalmopathy. Of the euthyroid patients, six had protector activity and thyroid non-suppressibility; firm goiters and high titers of thyroid antibodies were the rule in this group. We believe that these patients have three autoimmune diseases: Hashimoto's thyroiditis, Graves's thyroid disease and Graves's ophthalmopathy. Five euthyroid patients had no detectable protector activity or thyroid antibodies and had normal thyroid suppressibility; the thyroid was generally normal in size and consistence. These patients are interpreted as having "isolated" Graves's ophthalmopathy without any autoimmune thyroid disease. The remaining six patients showed dissociation between protector activity and thyroid non-suppressibility and cannot be classified as yet. Euthyroidism in Graves's ophthalmopathy may have more than one cause.
我们试图确定甲状腺功能正常的格雷夫斯眼病是单一疾病实体还是一组异质性疾病。长效甲状腺刺激物保护因子活性在33例格雷夫斯甲状腺功能亢进患者中有31例出现,但在17例甲状腺功能正常的格雷夫斯眼病患者中仅9例出现。在甲状腺功能正常的患者中,6例有保护因子活性且甲状腺不受抑制;该组患者通常有坚实的甲状腺肿和高滴度的甲状腺抗体。我们认为这些患者患有三种自身免疫性疾病:桥本甲状腺炎、格雷夫斯甲状腺病和格雷夫斯眼病。5例甲状腺功能正常的患者未检测到保护因子活性或甲状腺抗体,且甲状腺抑制功能正常;甲状腺大小和质地一般正常。这些患者被解释为患有“孤立性”格雷夫斯眼病,无任何自身免疫性甲状腺疾病。其余6例患者保护因子活性与甲状腺不受抑制之间存在分离,目前尚无法分类。格雷夫斯眼病患者甲状腺功能正常可能有多种原因。